Literature DB >> 21586339

Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.

Jin-Fang Cheng1, Guo-Hua Ni, Mei-Fang Chen, Yuan-Jian Li, Yong-Jin Wang, Chang-Lu Wang, Qiong Yuan, Rui-Zheng Shi, Chang-Ping Hu, Tian-Lun Yang.   

Abstract

Profilin-1, a regulator of actin polymerization, has recently been linked to vascular hypertrophy and remodeling. Whether profilin-1 is involved in angiotensin (Ang) II-induced proliferation of vascular smooth muscle cells leading to vascular remodeling in hypertension remains unclear. The present study was designed to analyze the correlation of profilin-1 and vascular remodeling during hypertension and to evaluate the role of profilin-1 in proliferation of vascular smooth muscle cells and the underlying mechanisms. The vascular morphology and the expression of profilin-1 in arterial tissues of spontaneously hypertensive rats and Wistar-Kyoto rats were assessed. The profilin-1 expression was significantly increased concomitantly with definite vascular remodeling by evaluating the media thickness, lumen diameter, media thickness-to-lumen diameter ratio and mean nuclear area in artery media in spontaneously hypertensive rats, which was inhibited by treatment with losartan. In cultured rat aortic smooth muscle cells (RASMCs), Ang II induced profilin-1 expression in a dose- and time-dependent manner. Knockdown of profilin-1 using small hairpin RNA inhibited Ang II-induced proliferation of RASMCs. Moreover, blockade of JAK2/STAT3 signaling pathway also inhibited Ang II-induced proliferation of RASMCs and profilin-1 expression. These results suggest that profilin-1 mediates the proliferation of RASMCs induced by Ang II via activation of Ang II type 1 receptor/JAK2/STAT3 signaling pathway, which may contribute to vascular remodeling in hypertension.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586339     DOI: 10.1016/j.vph.2011.04.003

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  14 in total

Review 1.  Profilin: many facets of a small protein.

Authors:  Rhonda J Davey; Pierre Dj Moens
Journal:  Biophys Rev       Date:  2020-07-13

Review 2.  Cofilin and profilin: partners in cancer aggressiveness.

Authors:  Joelle V F Coumans; Rhonda J Davey; Pierre D J Moens
Journal:  Biophys Rev       Date:  2018-07-19

3.  Monocyte chemoattractant protein-1 mediates angiotensin II-induced vascular smooth muscle cell proliferation via SAPK/JNK and ERK1/2.

Authors:  Hua-Li Yao; Feng-Hou Gao; Zong-Zhuang Li; Hong-Xian Wu; Meng-Dan Xu; Zhi Zhang; Qiu-Yan Dai
Journal:  Mol Cell Biochem       Date:  2012-04-17       Impact factor: 3.396

Review 4.  Nanoparticles in the diagnosis and treatment of vascular aging and related diseases.

Authors:  Hui Xu; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2022-07-11

5.  ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.

Authors:  Hai-Yan Jin; Bei Song; Gavin Y Oudit; Sandra T Davidge; Hui-Min Yu; Yan-Yan Jiang; Ping-Jin Gao; Ding-Liang Zhu; Guang Ning; Zamaneh Kassiri; Josef M Penninger; Jiu-Chang Zhong
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

Review 6.  The role of profilin-1 in cardiovascular diseases.

Authors:  Abigail Allen; David Gau; Partha Roy
Journal:  J Cell Sci       Date:  2021-05-07       Impact factor: 5.235

7.  Role and regulation of Abelson tyrosine kinase in Crk-associated substrate/profilin-1 interaction and airway smooth muscle contraction.

Authors:  Yinna Wang; Alyssa C Rezey; Ruping Wang; Dale D Tang
Journal:  Respir Res       Date:  2018-01-05

8.  Panaxquin quefolium diolsaponins dose-dependently inhibits the proliferation of vascular smooth muscle cells by downregulating proto-oncogene expression.

Authors:  Zhihao Wang; Yingkai Wang; Xuezhong Zhao
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200

9.  Neferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expression.

Authors:  Lulu Zheng; Yongwen Cao; Shao Liu; Zhenyu Peng; Saidan Zhang
Journal:  Exp Ther Med       Date:  2014-09-09       Impact factor: 2.447

10.  Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats.

Authors:  Dafeng Yang; Weiwei Liu; Liping Ma; Ya Wang; Jing Ma; Minna Jiang; Xu Deng; Fang Huang; Tianlun Yang; Meifang Chen
Journal:  Mol Med Rep       Date:  2017-09-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.